Alexander Cheung

6PUBLICATIONS
60CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 26, 2025
Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostate Cancer.

Rahul R Aggarwal, Jacqueline Vuky, David VanderWeele

|Apr 20, 2024
Dysregulation of CD4+ and CD8+ resident memory T, myeloid, and stromal cells in steroid-experienced, checkpoint inhibitor colitis.

Jun Yan He, Yang-Joon Kim, Elvira Mennillo

|Mar 29, 2024
Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer.

Atish D Choudhury, Lucia Kwak, Alexander Cheung

|Jan 26, 2024
Immune Modulation with RANKL Blockade through Denosumab Treatment in Patients with Cancer.

Hewitt Chang, Jaqueline Marquez, Brandon K Chen

|Jan 05, 2024
Neoadjuvant CD40 Agonism Remodels the Tumor Immune Microenvironment in Locally Advanced Esophageal/Gastroesophageal Junction Cancer.

Maira Soto, Erin L Filbert, Hai Yang

|Jan 02, 2023
Modulation of myeloid and T cells in vivo by Bruton's tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma.

Meenal Sinha, Courtney Betts, Li Zhang

Pageof 1

Frequent Collaborators

3 joint publications

Brandon K Chen

3 joint publications

Lawrence Fong

2 joint publications

Meenal Sinha

2 joint publications

Eric V Liu